Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis

NCT06624189 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT06624189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06624189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Enrolling by invitation
Start date
November 20, 2024
Completion date
July 24, 2026
Enrollment
1,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepatocellular carcinoma